Impaired cutaneous cell-mediated immunity in newly diagnosed rheumatoid arthritis

Panminerva Medica

Volumn 42, Issue 4, 2000, Pages 263-266

  Coaccioli, S ^a   Di Cato, L ^a   Marioli, D ^a   Patucchi, E ^a   Pizzuti, C ^a   Ponteggia, M ^a   Puxeddu, A ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Arthritis rheumatoid; Cellular; Skin tests Immunity

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; RHEUMATOID ARTHRITIS; SKIN; SKIN TEST;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN; SKIN TESTS;

EID: 0034569740     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fleming A, Crown JM, Corbett M. Early rheumatoid arthritis disease. Ann Rheum Dis 1976;35:357-63.
2. Arnett FC and Committee. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
3. Harris ED. Aetiology and pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors Textbook of Rheumatology. Philadelphia: WB Saunders Co., Chapter 1993;51: 833-74.
4. Maini RN, Zvaifler NJ. Rheumatoid arthritis and other sinovial disorders. In: Klippel JH, Dieppe PA, editors. Rheumatology. London: Mosby, 1998;Section 5:5.1.1-5.30.2.
5. Weyand CM, Goronzy JJ. Pathogenesis of rheumatoid arthritis. Adv Rheum 1977;81(1):29-55.
6. Goronzy JJ, Weyand CM. T cells in rheumatoid arthritis: paradigms and facts. Rheum Dis Clin North Am 1995;21:655-62.
7. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-31.
8. Waxman J, Lockshin MD, Schnapp JJ, Doneson IN. Cellular immunity in rheumatic disease. I. Rheumatoid arthritis. Arthritis rheum 1973;16:499-506.
9. Andrianakos AA, Sharp JT, Person DA, Lipsky MD, Duffy J. Cell-mediated immunity in rheumatoid arthritis. Ann Rheum Dis 1977;36:13-20.
10. Lloyd TM, Panush RS. Cell-mediated immunity in rheumatoid arthritis: impaired lymphocyte responsiveness, humoral immunosuppressants and correlation with clinical status in patients off drug therapy. J Rheumatol 1977;4:231-44.
11. Repo H, Leirisalo-Repo M, Gripenberg M, Koskimies S, Kontiainen S, Laitinen O. Yersinia arthritis, immune functions and histocompatibility antigens. Acta Pathol Microbiol Immunol Scand Sect C 1986;94:245-52.
12. Zilko PJ, Thevathasan M, Dawkins RL. Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA-B27. J Rheumatol 1977;3:49-52.
13. Runge LA. In vitro lymphocyte response in early rheumatoid arthritis. J Rheumatol 1981;8:468-75.
14. Paimela L, Johansson-Stephansson EA, Koskimies S, Leirisalo-Repo M. Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis. Clin Exp Rheum 1990;8:433-7.
15. Ritchie DM, Boyle JA, McInnes JM. Clinical studies with an articular index for assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:392-406.
16. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976;2:175-84.
17. Lorber A, Jackson WH, Simon TM. Effects of chrysotherapy on cell mediated immune response. J Rheumatol 1982;9(Suppl 8): 37-45.
18. Crout JE, Hepburn B, Ritts RE Jr. Suppression of lymphocyte transformation after aspirin ingestion. N Eng J Med 1975;292:221-3.